Allied Sciences research is a field where getting things right matters enormously. The research we publish may influence clinical decisions, intervention strategies, and patient outcomes. That responsibility shapes how we approach every manuscript that comes through our doors.

We've designed our review process to be rigorous but constructive. When reviewers identify problems, we expect them to suggest solutions where possible. A good review doesn't just point out what's wrong — it helps authors understand how to fix it.

We use a double-blind peer review process. This means authors don't know who is reviewing their work, and reviewers don't know whose work they're reviewing. We remove author names, institutional affiliations, and other identifying details before manuscripts go out for review.

Why do we do this? Because we want manuscripts judged on their merits alone. A paper from a well-known institution shouldn't get an easier ride than one from a smaller research institution. A junior researcher's work deserves the same fair hearing as a department head's. Blinding helps level the playing field.

Of course, blinding isn't perfect — sometimes reviewers can guess who wrote something based on the topic or methodology. But it reduces bias, and that's worth doing.

We give our reviewers clear guidance on what to assess. Here's what they're looking at:

We select reviewers based on their expertise in the manuscript's subject area and their track record in research and publication. These are practicing scientists, researchers, and academics who understand both the clinical realities and the methodological standards of the field.

Our reviewers are external to the editorial board. We believe this independence is important — it prevents any appearance that decisions are made by an insular group.

We typically assign two reviewers to each manuscript. If their assessments diverge significantly, we may seek a third opinion. The final decision rests with the editors, but reviewer input is central to that decision.

If a reviewer feels unable to provide an unbiased evaluation for any reason, they should decline the assignment. If delays are unavoidable, early notice is appreciated so alternative arrangements can be made.

We mentioned earlier that our goal extends beyond simply accepting or rejecting manuscripts. We're particularly committed to supporting emerging researchers — those who may be new to publishing and still developing their skills.

Not every promising study arrives perfectly packaged. Sometimes good science is let down by weak writing or incomplete analysis. When we see potential, we try to work with authors to realize it. This takes more time and effort than simple rejection, but we think it's worthwhile.

That said, we have standards, and we maintain them. Supportive doesn't mean accepting work that isn't ready. It means giving authors a fair chance to improve.